Jiangxi Synergy Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIVAROXABAN, with a corresponding US DMF Number 31601.
Remarkably, this DMF maintains an Active status since its submission on March 16, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 09, 2022, and payment made on November 10, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II